Viruses as oncolytic agents: A new age for "therapeutic" viruses?

Journal of the National Cancer Institute

Volumn 86, Issue 16, 1994, Pages 1185-1186

  Kenney, Shannon ^b   Pagano, Joseph S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; EXPERIMENTAL NEOPLASM; HERPES SIMPLEX VIRUS; HUMAN; NEOPLASM; NEWCASTLE DISEASE PARAMYXOVIRUS; NOTE; VIRUS;

ANIMAL; HUMAN; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEWCASTLE DISEASE VIRUS; SIMPLEXVIRUS; VIRUSES;

EID: 0028775663     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/86.16.1185     Document Type: Editorial

References (16)

1. Lorence RM, Reichard KW, Katubig BB, et al: Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy. J Natl Cancer Inst 86:1228-1233, 1994
2. Jia WW, McDermott M, Goldie J, et al: Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1. J Natl Cancer Inst 86:1209-1215, 1994
3. Webb HE, Smith CE: Viruses in the treatment of human cancer. Lancet 1:1206-1208, 1970
4. Reichard KW, Lorence RM, Cascino CJ, et al: Newcastle disease virus selectively kills human tumor cells. J Surg Res 52:448-453, 1992
5. Asada T: Treatment of human cancer with mumps virus. Cancer 34:1907-1928, 1974
6. Gross S: Measles and leukaemia. Lancet 1:397-398, 1971
7. Taylor MW, Cordell B, Souhrada M, et al: Viruses as an aid to cancer therapy: regression of solid and ascites tumors in rodents after treatment of bovine enterovirus. Proc Natl Acad Sci U S A 68:836-840, 1971
8. Cassell W, Garrett RE: Newcastle disease virus as an antineoplastic agent. Cancer 18:863, 1965
9. Lorence RM, Rood PA, Kelley KW: Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-a and augmentation of its cytotoxicity. J Natl Cancer Inst 80:1305-1312, 1988
10. Cassel WA, Murray DR, Phillips HS: A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate. Cancer 52:856-860, 1983
11. Csatary LK, Eckhardt S, Bukosza I, et al: Attenuated veterinary virus vaccine for the treatment of cancer. Cancer Detect Prev 17:619-627, 1993
12. Coen DM, Kosz-Vnenchak M, Jacobson JG, et al: Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A 86:4736-4740, 1989
13. Martuza RL, Malick A, Markert JM, et al: Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252:854-856, 1991
14. Markert JM, Malick A, Coen DM, et al: Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery 32:597-603, 1993
15. Asada T: A new attempt for cancer therapy. Jpn Red Cross Med J 16:9-19, 1963
16. Culver KW, Ram Z, Wallbridge S, et al: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors [see comment citations in Medline], Science 256:1550-1552, 1992